adenoma sebaceum

Small growths (adenoma sebaceum) on the face may be removed by laser treatment.

Adenoma sebaceum may at times be associated with tuberous sclerosis.

Red patches on the face containing many blood vessels (adenoma sebaceum)

P. Schuster described a patient with adenoma sebaceum and epilepsy but of normal intelligence.

Pringle's adenoma sebaceum would become a common eponym for the facial rash.

The term adenoma sebaceum is a misnomer.

Several years later, physicians would rcognise that the combination of adenoma sebaceum, epilepsy and learning disability was diagnostic for tuberous sclerosis.

The geneticist Robert James Gorlin suggested in 1981 that it could be a useful acronym for epilepsy, low intelligence, and adenoma sebaceum.

Pringle adopted the term "adenoma sebaceum" from Félix Balzer's phrase "adénomes sébacés".

Facial angiofibromas ("adenoma sebaceum"): A rash of reddish spots or bumps, which appear on the nose and cheeks in a butterfly distribution.

Cutaneous and visceral lesions may occur, including adenoma sebaceum, cardiac rhabdomyomas, and renal angiomyolipomas.

JJ Pringle is primarily remembered for the eponym: Pringle's Adenoma Sebaceum.

The neurologist Vogt (1908) established a diagnostic triad of epilepsy, idiocy, and adenoma sebaceum (an obsolete term for facial angiofibroma).

Balzer is also responsible for coining the term "adénomes sébacés" (adenoma sebaceum) to describe the papular facial rash of tuberous sclerosis.

In 1967 he broke the established wisdom that tuberous sclerosis was defined by Vogt's triad of mental retardation, epilepsy and adenoma sebaceum (a papular facial rash).

French dermatologists François Henri Hallopeau and Émile Leredde published a case of adenoma sebaceum that was of a hard and fibrous nature.

In 1885, Leredde published with François Henri Hallopeau a report on the papular facial rash of tuberous sclerosis, then known as "adénomes sébacés" (adenoma sebaceum).

Vogt's triad of epilepsy, idiocy, and adenoma sebaceum held for 60 years until research by Manuel Gómez discovered that fewer than a third of patients with TSC had all three symptoms.

In the late 19th century, notable physicians working in the great European teaching hospitals first described the cortical and dermatological manifestations; these early researchers have been awarded with eponyms such as "Bourneville's disease" and "Pringle's adenoma sebaceum".